What is the recommended approach to test for lymphedema?

Testing for Lymphedema

For upper extremity lymphedema, circumferential measurement should be used as the primary diagnostic tool when a difference ≥2 cm is detected at two contiguous measurement points compared to the contralateral limb, and bioimpedance analysis (BIA) should be used to detect subclinical and early-stage (Stage 0-1) lymphedema before visible swelling occurs. 1

Diagnostic Approach by Stage

Early Detection (Stage 0-1: Subclinical)

• Bioimpedance spectroscopy (BIS) is the recommended tool for detecting lymphatic transport impairments before visible swelling develops 1
• L-Dex score >10 above preoperative baseline is diagnostic when baseline measures are available 1
• L-Dex score >7.1 should be used as diagnostic criteria when no preoperative assessment is available 1
• BIS demonstrates good reliability (ICC 0.89) and can detect alterations in extracellular fluid before volume changes 2

Clinical Lymphedema (Stage 1 or Greater)

Primary diagnostic method:

• Circumferential measurement at multiple points along the affected limb, with diagnosis confirmed when ≥2 cm difference exists at two contiguous measurement points 1
• High reliability (intrarater and interrater ICCs 0.98-0.99) with standard error of measurement 6.6% 2

Volume-based criteria:

• ≥5% volume change from baseline (above and below the elbow) is diagnostic when preoperative measures are available 1
• Volume ratio of 1.04 may be indicative of upper extremity lymphedema 1
• Water displacement showing >200 mL difference compared to contralateral arm OR >10% interlimb difference confirms diagnosis 1
• Water displacement has excellent reliability (ICC 0.98-0.99) with standard error 3.6% and serves as the reference test for upper extremity lymphedema 2

Clinical Assessment Components

Physical Examination

• Palpate for fibrosis, pitting edema, and tissue quality changes in the affected quadrant 1
• Stemmer's sign (inability to pinch skin at base of second toe or finger) is present in 92% of lymphedema cases and is highly useful for diagnosis 3
• Assess for asymmetry, skin changes, and functional limitations 1

Patient-Reported Symptoms

• Self-reported swelling, heaviness, and numbness should trigger formal diagnostic testing 1
• Use validated questionnaires: Norman Questionnaire or Morbidity Screening Tool 1

Advanced Imaging (When Indicated)

Diagnostic imaging modalities:

• Ultrasound should be used to identify tissue changes and confirm diagnosis 1
• Indocyanine green (ICG) lymphography allows visualization of lymphatic vessel anatomy, pumping capacity, and dermal reflux with diagnostic ability similar to lymphoscintigraphy but less invasive and lower cost 3
• Lymphoscintigraphy may be used to detect lymphatic system impairment, particularly when combined with quantitative nodal uptake analysis 1, 4
• MRI or CT may be used as diagnostic tools for complex cases 1

Assessment Tools NOT Recommended for Diagnosis

• Perometry: Use for volume assessment only, not diagnosis 1
• Tissue Dielectric Constant: Assessment tool only, not diagnostic 1
• DEXA: Assessment to calculate arm volume, not diagnostic 1
• Tonometry: Not recommended as a diagnostic tool 1

Site-Specific Considerations

Head and Neck Lymphedema

• Use Modified Head and Neck External Lymphedema and Fibrosis assessment criteria in conjunction with circumferential measurement 1
• Single-point circumferential measurement under the jawline useful for assessment but not validated as diagnostic test 1

Hand Lymphedema

• Figure-of-8 circumferential measurement may assess hand volume but has not been studied as a diagnostic test 1

Critical Pitfalls

Important caveat for BIA in advanced disease: In moderate to late-stage lymphedema with fibrosis and tissue changes, BIA may show decreasing extracellular fluid despite increased tissue volume, potentially leading to false-negative results 1

Volume measurement limitations: Calculated volume differential <200 mL cannot be used to rule out lymphedema; values ≥200 mL help rule in diagnosis 1

Timing matters: For breast cancer-related lymphedema, performing circumferential measurements at 6 months post-surgery (using the two-contiguous-point criterion) provides the best prediction of long-term lymphedema development (60% posterior probability) 5

Referral Threshold

Patients with clinical symptoms or swelling suggestive of lymphedema should be referred to a therapist knowledgeable about lymphedema diagnosis and treatment (physical therapist, occupational therapist, or lymphedema specialist) 1